Rozerem and Weight control - a phase IV clinical study of FDA data

Summary:

Weight control is reported as a side effect among people who take Rozerem (ramelteon), especially for people who are female, 40-49 old, have been taking the drug for 6 - 12 months also take Clonazepam, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Weight control when taking Rozerem. It is created by eHealthMe based on reports of 7,343 people who have side effects when taking Rozerem from the FDA, and is updated regularly.

What is Rozerem?

Rozerem has active ingredients of ramelteon. It is often used in insomnia. eHealthMe is studying from 7,539 Rozerem users. Check the latest studies of Rozerem.

What is Weight control?

Weight control is found to be associated with 1,899 drugs and 2,335 conditions by eHealthMe. Check the latest studies of Weight control.

On May, 27, 2026

7,343 people reported to have side effects when taking Rozerem.
Among them, 31 people (0.42%) have Weight control.

Among these 31 people:

How long have people been on Rozerem when they have Weight control? *

What is the gender of people who have Weight control when taking Rozerem? *

female: 67.74 %
male: 32.26 %

What is the age of people who have Weight control when taking Rozerem? *

What are other drugs people take besides Rozerem? *

What are other side effects people have besides Weight control? *

Diabetes: 13 people, 41.94%
Type 2 Diabetes: 10 people, 32.26%
High Blood Pressure: 8 people, 25.81%
Neuropathy Peripheral (surface nerve damage): 7 people, 22.58%
Weakness: 7 people, 22.58%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 7 people, 22.58%
Speech Impairment (Adult) (inability to speak (adult)): 7 people, 22.58%
Back Pain: 7 people, 22.58%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 19.35%
Dizziness: 6 people, 19.35%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 12 people, 38.71%
Stress And Anxiety: 9 people, 29.03%
Depression: 6 people, 19.35%
Panic Disorder: 6 people, 19.35%
Muscle Spasms (muscle contraction): 4 people, 12.90%
Breast Cancer Metastatic: 3 people, 9.68%
Diarrhea: 3 people, 9.68%
Pain: 3 people, 9.68%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 9.68%
High Blood Pressure: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Rozerem and have Weight control?

- Check whether Weight control is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rozerem:

Rozerem (7,539 reports)

Weight control treatments and more:

Weight control (62,431 reports)

Browse all side effects of Rozerem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight control:

Weight control (1,899 drugs)

Browse all the conditions that are associated with Weight control:

Weight control (2,335 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramelteon (the active ingredients of Rozerem) and Rozerem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.